 |
20-mer oligonucleotide complementary to Akt mRNA |
|---|---|
| Trade Name | |
| Orphan Indication | Ovarian cancer |
| USA Market Approval | USA |
| USA Designation Date | 2004-12-01 00:00:00 |
| Sponsor | Rexahn Corporation;9620 Medical Center Drive;Rockville, Maryland, 20850 |
| |
20-mer oligonucleotide complementary to Akt mRNA |
|---|---|
| Trade Name | |
| Orphan Indication | Ovarian cancer |
| USA Market Approval | USA |
| USA Designation Date | 2004-12-01 00:00:00 |
| Sponsor | Rexahn Corporation;9620 Medical Center Drive;Rockville, Maryland, 20850 |